Novartis AG announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, ...

In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and ...

The sector-specific tariffs are putting pressure on businesses and foreign nations as they try to navigate Trump’s constantly ...

Australia is “urgently seeking more detail” on U.S. President Donald Trump’s threat to raise tariffs up to 200% on ...

Johnson & Johnson (JNJ) has reportedly revised its forecast of the impact of U.S. President Donald Trump’s tariffs to $200 ...

Donald Trump again has threatened a tariff on imported drugs, but has given the drug makers a year or so "to get their act ...

Irish-made medicines heading to the US face steep new duties, raising alarm among patients, producers and investors on both ...

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...